pipette
ESEspañol

Beat-to-beat blood pressure variability and Alzheimers disease pathophysiology

T. Lohman, J. Joyce, M. Quiring, B. Lashin, A. Kapoor, A. C. Engstrom, K. Law, F. Ferrer, L. Contreras, J. P. Alitin, A. Gaubert, K. Rodgers, E. Head, R. Malhas, N. Pahlevan, D. A. Nation

Preprint

In the authors' words

Introduction: Elevated blood pressure variability (BPV) is predictive of Alzheimers disease neuropathologic change observed with AD biomarkers. However, prior studies have largely focused on visit-to-visit BPV, which may be influenced by antihypertensive medication adherence and other external factors. Few studies have investigated beat-to-beat BPV, a reliable and direct measure of cardiovascular and autonomic function relevant to AD. Methods: Independently living older adults (N=132) were recruited from the community. Participants underwent continuous blood pressure monitoring and venipuncture. Plasma p-Tau217, p-Tau181, GFAP, NfL, and amyloid-{beta}42/40 ratio were assessed. Linear regression examined the relationship between beat-to-beat systolic BPV and plasma AD biomarkers with and without adjustment for age, sex, systolic blood pressure, and apolipoprotein E4 (APOE4) carrier status. Results: Elevated beat-to-beat BPV was associated with elevated plasma p-Tau217 ({beta}=0.32, p=0.008), plasma p-Tau181 ({beta}=0.22, p=0.05), and plasma GFAP ({beta}=0.41, p=0.00001). Elevated BPV was not associated with plasma amyloid-{beta}42/40 ratio or plasma NfL. Discussion: Increased beat-to-beat BPV is associated with increased Core 1 T1 biomarkers of phosphorylated and secreted AD tau in blood plasma (i.e., pTau217, pTau181), but not with amyloid-{beta}42/40 ratio, a biomarker more exclusively indexing cerebral amyloid retention alone. Elevated BPV was also associated with higher plasma GFAP, a marker of astrocyte reactivity. These findings are consistent with prior studies relating visit-to-visit BPV to AD biomarkers, suggesting that intrinsic cardiovascular and/or autonomic factors underlie links between BPV and AD.

Main resultThe abstract does not state a limitation.

Appeared: Friday, November 13. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.10.26367476